Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	646.4	901.9	286.7	1,278	786.03	688.94
Short-Term Investments	188.2	46.7	835.9	31	239.62	193.46
Cash & Short-Term Investments	834.6	948.6	1,123	1,309	1,026	882.4
Cash Growth	-16.99%	-15.50%	-14.22%	27.60%	16.23%	74.49%
Accounts Receivable	1.7	13.1	6.4	100.04	0.09	50.41
Total Trade Receivables	1.7	13.1	6.4	100.04	0.09	50.41
Inventory	37.1	32	23.9	19.43	10.35	1.75
Other Current Assets	209.3	253.4	131	69.61	63.03	15.3
Total Current Assets	1,083	1,247	1,284	1,498	1,099	949.85
Net Property, Plant & Equipment	452.5	401.5	201.2	189.68	161.67	142.96
Other Intangible Assets	-	-	-	4.06	3.41	4.68
Long-Term Investments	-	-	-	4.36	-	4.71
Other Long-Term Assets	61.5	85.1	185.1	152.71	66.76	17.27
Total Assets	1,597	1,734	1,670	1,849	1,331	1,119
Accounts Payable	74.3	83	38.6	30.66	32.89	7.04
Accrued Expenses	130.2	195.4	166.2	122.31	184.11	123.56
Current Portion of Leases	11.2	7.4	4.8	3.18	3.56	0.91
Unearned Revenue	6	11.3	46.9	53.01	-	-
Other Current Liabilities	287.4	339.3	21.2	7.27	77.22	97.69
Total Current Liabilities	509.1	636.4	277.7	216.42	297.79	229.2
Long-Term Leases	112.1	87.2	44.6	44.17	20.04	1.59
Other Long-Term Liabilities	7.8	8	307.3	336.65	268.82	122.72
Total Long-Term Liabilities	119.9	95.2	351.9	380.82	288.86	124.32
Total Liabilities	629	731.6	629.6	597.24	586.65	353.52
Common Stock	0.1	0.1	0.1	0.04	0.03	0.03
Additional Paid-in Capital	967.6	1,002	1,041	1,251	744.28	765.91
Shareholders' Equity	967.7	1,002	1,041	1,251	744.31	765.94
Total Liabilities & Equity	1,597	1,734	1,670	1,849	1,331	1,119
Total Debt	123.3	94.6	49.4	47.34	23.6	2.5
Net Cash (Debt)	711.3	854	1,073	1,261	1,002	879.89
Net Cash Growth	-16.71%	-20.42%	-14.92%	25.88%	13.88%	75.17%
Net Cash Per Share	3.85	4.63	5.87	7.16	6.30	6.25
Book Value	967.7	1,002	1,041	1,251	744.31	765.94
Book Value Per Share	5.24	5.44	5.69	7.11	4.68	5.44
Tangible Book Value	967.7	1,002	1,041	1,247	740.9	761.26
Tangible Book Value Per Share	5.24	5.44	5.69	7.08	4.66	5.40